191 related articles for article (PubMed ID: 12639568)
1. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.
Huang W; Naughton MA; Yang H; Su T; Dam S; Wong PW; Arfsten A; Edwards S; Sinha U; Hollenbach S; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2003 Feb; 13(4):723-8. PubMed ID: 12639567
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and SAR of amino acid derivatives as factor Xa inhibitors.
Su T; Wu Y; Doughan B; Jia ZJ; Woolfrey J; Huang B; Wong P; Park G; Sinha U; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2001 Nov; 11(22):2947-50. PubMed ID: 11677132
[TBL] [Abstract][Full Text] [Related]
4. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor.
Nishida H; Miyazaki Y; Kitamura Y; Ohashi M; Matsusue T; Okamoto A; Hosaka Y; Ohnishi S; Mochizuki H
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1237-44. PubMed ID: 11605647
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
7. Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.
Maduskuie TP; McNamara KJ; Ru Y; Knabb RM; Stouten PF
J Med Chem; 1998 Jan; 41(1):53-62. PubMed ID: 9438022
[TBL] [Abstract][Full Text] [Related]
8. 1,2-Dibenzamidobenzene inhibitors of human factor Xa.
Herron DK; Goodson T; Wiley MR; Weir LC; Kyle JA; Yee YK; Tebbe AL; Tinsley JM; Mendel D; Masters JJ; Franciskovich JB; Sawyer JS; Beight DW; Ratz AM; Milot G; Hall SE; Klimkowski VJ; Wikel JH; Eastwood BJ; Towner RD; Gifford-Moore DS; Craft TJ; Smith GF
J Med Chem; 2000 Mar; 43(5):859-72. PubMed ID: 10715153
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides.
Jia ZJ; Wu Y; Huang W; Goldman E; Zhang P; Woolfrey J; Wong P; Huang B; Sinha U; Park G; Reed A; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2002 Jun; 12(12):1651-5. PubMed ID: 12039583
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM
Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520
[TBL] [Abstract][Full Text] [Related]
12. Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.
Shi Y; Li C; O'Connor SP; Zhang J; Shi M; Bisaha SN; Wang Y; Sitkoff D; Pudzianowski AT; Huang C; Klei HE; Kish K; Yanchunas J; Liu EC; Hartl KS; Seiler SM; Steinbacher TE; Schumacher WA; Atwal KS; Stein PD
Bioorg Med Chem Lett; 2009 Dec; 19(24):6882-9. PubMed ID: 19896847
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa.
Phillips GB; Buckman BO; Davey DD; Eagen KA; Guilford WJ; Hinchman J; Ho E; Koovakkat S; Liang A; Light DR; Mohan R; Ng HP; Post JM; Shaw KJ; Smith D; Subramanyam B; Sullivan ME; Trinh L; Vergona R; Walters J; White K; Whitlow M; Wu S; Xu W; Morrissey MM
J Med Chem; 1998 Sep; 41(19):3557-62. PubMed ID: 9733480
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
[TBL] [Abstract][Full Text] [Related]
16. The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studies.
Galemmo RA; Maduskuie TP; Dominguez C; Rossi KA; Knabb RM; Wexler RR; Stouten PF
Bioorg Med Chem Lett; 1998 Oct; 8(19):2705-10. PubMed ID: 9873607
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors.
Yoshikawa K; Yoshino T; Yokomizo Y; Uoto K; Naito H; Kawakami K; Mochizuki A; Nagata T; Suzuki M; Kanno H; Takemura M; Ohta T
Bioorg Med Chem Lett; 2011 Apr; 21(7):2133-40. PubMed ID: 21345673
[TBL] [Abstract][Full Text] [Related]
19. Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.
Quan ML; Ellis CD; He MY; Liauw AY; Woerner FJ; Alexander RS; Knabb RM; Lam PY; Luettgen JM; Wong PC; Wright MR; Wexler RR
Bioorg Med Chem Lett; 2003 Feb; 13(3):369-73. PubMed ID: 12565931
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase optimisation of achiral amidinobenzyl indoles as potent and selective factor Xa inhibitors.
Heinelt U; Herok S; Matter H; Wildgoose P
Bioorg Med Chem Lett; 2001 Jan; 11(2):227-30. PubMed ID: 11206465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
